From WisPolitics.com/WisBusiness.com …
— WARF and California venture capital firm Nexus NeuroTech Ventures are launching a new challenge grant aimed at advancing innovative neurotechnologies on the UW-Madison campus.
“We want to recognize and support UW-Madison researchers who are developing groundbreaking diagnostic and treatment methods for neurological conditions,” Wisconsin Alumni Research Foundation CEO Erik Iverson said in a statement. “Through our collaboration with Nexus NeuroTech Ventures, we aim to advance innovative solutions to these critical health challenges.”
The WARF Accelerator Neurotechnology Challenge Grant will consider projects, including those in the early stages of development, that advance new technologies for diagnosing and treating brain disorders such as Parkinson’s disease or bipolar disorder.
Cross-cutting clinical areas including seizures, cognitive dysfunction and mood disorders will also be considered, according to the announcement.
To qualify, project teams must include a principal investigator at UW-Madison or the university-affiliated Morgridge Institute for Research in Madison. Concepts must be new to WARF and demonstrate technical readiness and commercial potential.
The WARF Accelerator will award up to five grants from a $100,000 pool.
Applications can be done here and are due by April 1.
See more at Madison Startups.
Top Stories
– Obesity rates soaring globally in ‘monumental social failure’, study says
– Exclusive: US health agency says employees can apply for early retirement
– Warren presses RFK Jr. to clarify vaccine policy ‘intentions’
– Trump’s FDA pick made his name by bashing the medical establishment. Soon he may be leading it
– He Fought Claims of Harm From Infant Formula. Now He Regulates It.
– States Facing Doctor Shortages Ease Licensing Rules for Foreign-Trained Physicians
Press Releases
– OsteoStrong: Opens new location in Cottage Grove, Wis.
– Thedacare Medical Center-Shawano: Recognized by Chartis as a top 100 critical access hospital
